Document is current
Any future updates will be listed below
-
Authors
Kamenish, Katie A.
Cahill, Emma N. https://orcid.org/0000-0003-3054-1708
Robinson, Emma S. J. https://orcid.org/0000-0002-1299-6541
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/V015028/1)
- License Information
-
More Information
Article History
Received: 29 October 2025
Revised: 4 February 2026
Accepted: 16 February 2026
First Online: 26 February 2026
Competing interests
: ESJR and ENC have received collaborative research funding from Boehringer Ingelheim. ESJR has received research funding from Compass Pathways Ltd, Eli Lilly, MSD, Pfizer and undertaken contract research or paid consultancy with Compass Pathways Ltd., IRLab therapeutics, Pangea Botanicals, SmallPharma. KAK has no conflicts of interests to declare.
